Title : Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas.

Pub. Date : 2016 Mar

PMID : 26811014






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Three drugs are now approved in the US to treat relapsed/refractory CTCL including the oral retinoid, bexarotene, and histone deacetylase inhibitors, romidepsin and vorinostat. Bexarotene TSPY like 2 Homo sapiens